Leukostasis and hyperleukocytosis: Difference between revisions
ClaireLewis (talk | contribs) |
|||
| Line 52: | Line 52: | ||
==Management== | ==Management== | ||
*Hyperleukocytosis (asymptomatic) | *Hyperleukocytosis (asymptomatic) | ||
** | **[[Hydroxyurea]] may be all that is required | ||
*Leukostasis | *Leukostasis | ||
**IV hydration | **IV hydration | ||
| Line 58: | Line 58: | ||
**Chemotherapy | **Chemotherapy | ||
***Only treatment proven to improve survival | ***Only treatment proven to improve survival | ||
**Hydroxyurea + leukapheresis | **[[Hydroxyurea]] + leukapheresis | ||
***Can be use for cytoreduction if chemo will be delayed | ***Can be use for cytoreduction if chemo will be delayed | ||
*[[Allopurinol]] may help prevent [[Tumor lysis syndrome]] | *[[Allopurinol]] may help prevent [[Tumor lysis syndrome]] | ||
*Consider rasburicase | *Consider [[rasburicase]] | ||
*Broad spectrum antibiotics | *Broad spectrum [[antibiotics]] | ||
**The leading cause of death in blast crisis is infection (patients are functionally neutropenic) | **The leading cause of death in blast crisis is infection (patients are functionally neutropenic) | ||
Revision as of 21:28, 27 May 2019
Background
- Hyperleukocytosis is lab abnormality of WBC >50-100K
- Blood viscosity increases
- Leukostasis is symptomatic hyperleukocytosis; it is a medical emergency
- 20-40% of patients with leukostasis die within 1st week of presentation
Clinical Features
- Fever
- 80% of patients
- May be due to inflammation associated with leukostasis or concurrent infection
- Brain Leukostasis
- Pulmonary Leukostasis
Differential Diagnosis
Oncologic Emergencies
Related to Local Tumor Effects
- Malignant airway obstruction
- Bone metastases and pathologic fractures
- Malignant spinal cord compression
- Malignant Pericardial Effusion and Tamponade
- Superior vena cava syndrome
Related to Biochemical Derangement
- Hypercalcemia of malignancy
- Hyponatremia due to SIADH
- Adrenal insufficiency
- Tumor lysis syndrome
- Carcinoid syndrome
Related to Hematologic Derangement
Related to Therapy
- Chemotherapy-induced nausea and vomiting
- Cytokine release syndrome
- Chemotherapeutic drug extravasation
- Differentiation syndrome (retinoic acid syndrome) in APML
- Stem cell transplant complications
- Catheter-related complications
- Tunnel infection
- Exit site infection
- CVC obstruction (intraluminal or catheter tip thrombosis)
- Catheter-related venous thrombosis
- Fracture of catheter lumen
- Oncologic therapy related adverse events
Evaluation
Work-Up
- CBC
- DIC labs
- DIC occurs in up to 40% of patients
- FDP, d-dimer, fibrinogen, coags
- Tumor Lysis Syndrome labs
- TLS occurs in up to 10% of patients
- Chemistry
- Uric acid
- Calcium
- Phosphate
Evaluation
- High degree of suspicion needed to make the diagnosis
- WBC count usually >100K; can have symptoms with WBC as low as 50K
- CXR
- Interstial or alveolar infiltrates
Management
- Hyperleukocytosis (asymptomatic)
- Hydroxyurea may be all that is required
- Leukostasis
- IV hydration
- Prevent dehydration which can worsen condition
- Chemotherapy
- Only treatment proven to improve survival
- Hydroxyurea + leukapheresis
- Can be use for cytoreduction if chemo will be delayed
- IV hydration
- Allopurinol may help prevent Tumor lysis syndrome
- Consider rasburicase
- Broad spectrum antibiotics
- The leading cause of death in blast crisis is infection (patients are functionally neutropenic)
Disposition
- Admit to ICU